US patent for needle-free penile syringe:
This article was originally published in Clinica
Executive Summary
Medi-Ject has received a US patent covering its needle-free syringe for delivering drugs into the penis. The new device for so-called intracorporal delivery is a modification of the company's needle-free technology which is already available commercially for the administration of insulin and growth hormones. The modified Medi-Jector system would encourage significantly more men to take advantage of erectile dysfunction therapy, said the Minneapolis, Minnesota-based company. In addition to starting Phase I/II clinical studies to assess the safety and efficacy of needle-free delivery, Medi-Ject plans to test an approved drug.